Immunosuppressive Agents: all 5,940 studies that test it
Page 54 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Methotrexate and Cyclosporine in Treatment of Early Rheumatoid ArthritisCompletedNCT00209859Phase 4
- Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's DiseaseTerminatedNCT00209014Phase 2
- Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic MalignanciesCompletedNCT00208923Phase 2
- Biologic Correlative Taxotere/ACCompletedNCT00206466Phase 2
- Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementCompletedNCT00206388Phase 1
- Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)CompletedNCT00206219Phase 3
- A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV DiseaseCompletedNCT00205231Not applicable
- Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)Status unknownNCT00204568Phase 2
- Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant RecipientsCompletedNCT00204321Phase 4
- Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney TransplantationStatus unknownNCT00204191Phase 4
- Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00201812Phase 1
- Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic LeukemiaCompletedNCT00201721Phase 2
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNCT00201708Phase 2
- Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedNCT00201682Phase 1/2
- An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerCompletedNCT00201357Phase 2
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedNCT00198991Phase 4
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00198978Phase 4
- Prevention of Diabetes Progression Trial (PDPT)CompletedNCT00198146Phase 2
- Comparison of Immunosuppression Protocols After LTx in ChildrenCompletedNCT00195988Phase 4
- Study Evaluating Sirolimus in Kidney Transplant Recipients in IndiaCompletedNCT00195481Phase 4
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00195468Phase 4
- Two-Dose Methotrexate for Ectopic PregnancyCompletedNCT00194272Phase 3
- Idarubicin Based Combined Modality Therapy in Primary CNS LymphomaCompletedNCT00193973Phase 2
- Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple MyelomaCompletedNCT00193544Phase 2
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast CancerCompletedNCT00193115Phase 2
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast CancerTerminatedNCT00193102Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- High Dose CHOP in LymphomaCompletedNCT00192764Phase 2
- Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein PurpuraCompletedNCT00190229Not applicable
- A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic UrticariaTerminatedNCT00189878Phase 2
- A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney TransplantationCompletedNCT00189839Phase 3
- A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.CompletedNCT00189826Phase 3
- Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent AsthmaCompletedNCT00189787Phase 2
- A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT RecipientsCompletedNCT00189761Phase 2
- A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-CompletedNCT00189748Phase 2
- Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent AsthmaCompletedNCT00189722Phase 2
- Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney TransplantCompletedNCT00188955Phase 4
- Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung TransplantCompletedNCT00188825Phase 3
- Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)CompletedNCT00188136Phase 2
- Pilot Trial for Implementation of a MPA PK Monitoring StrategyCompletedNCT00187915Not applicable
- Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Treatment for Patients With Stage III or IV Non-Hodgkin LymphomaCompletedNCT00187122Not applicable
- A Study of Children With Refractory or Relapsed ALLCompletedNCT00187083Phase 3
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
- Study for Treatment of Cancer in Children With Ataxia-telangiectasiaCompletedNCT00187057Not applicable
- Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00187005Phase 3
- Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid LeukemiaCompletedNCT00186966Phase 3
- Therapy for Children With Advanced Stage High Risk NeuroblastomaCompletedNCT00186849Phase 2
- Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell DiseaseCompletedNCT00186810Phase 2
- Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic AnemiaCompletedNCT00186797Not applicable
- Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHLCompletedNCT00185445Phase 2
- The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in HumansCompletedNCT00184886Not applicable
- Intensified Post Remission Therapy Containing PEG-AsparaginaseCompletedNCT00184041Phase 2
- Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With TransplantCompletedNCT00182663Phase 2
- The Vienna Prograf and Endothelial Progenitor Cell StudyCompletedNCT00182559Phase 4
- The Use of Daclizumab and Anti-Thymocyte Globulin in Lung TransplantationCompletedNCT00181142Phase 2/3
- Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem GliomaCompletedNCT00179881Phase 2
- Effects of Ligands on Human Hair Follicles Grafted Onto SCID MiceCompletedNCT00177099Phase 1
- Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate CancerCompletedNCT00174863Phase 2
- Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant RecipientsCompletedNCT00171743Phase 4
- Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant RecipientsCompletedNCT00171509Phase 4
- Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsCompletedNCT00171496Phase 4
- Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant RecipientsCompletedNCT00170885Phase 4
- Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant RecipientsCompletedNCT00170859Phase 4
- Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant PatientsCompletedNCT00170833Phase 3
- Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free RegimenCompletedNCT00170820Phase 4
- Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.CompletedNCT00170794Phase 3
- Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no SteroidsCompletedNCT00170053Phase 1
- Efficacy and Safety of BG00012 in MSCompletedNCT00168701Phase 2
- Study Evaluating Sirolimus in Kidney Transplant Recipients.CompletedNCT00167947Phase 3
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)CompletedNCT00167583Phase 3
- Sirolimus Blood Concentrations on Conversion From Oral Solution to TabletsStatus unknownNCT00166842Phase 4
- The Effect of Sirolimus on the Pharmacokinetics of TacrolimusStatus unknownNCT00166829Phase 4
- The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant PatientsStatus unknownNCT00166816Phase 4
- A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver TransplantationCompletedNCT00166556Phase 2
- A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive CancerCompletedNCT00165451Phase 2
- Thalidomide in Combination With Temodar in Patients With Neuroendocrine TumorsCompletedNCT00165230Phase 2
- Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal CarcinomaCompletedNCT00165217Phase 2
- Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00162760Phase 2
- Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate BackgroundCompletedNCT00162292Phase 1
- The Study of Abatacept in Combination With EtanerceptCompletedNCT00162279Phase 2
- An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF TherapyCompletedNCT00162201Phase 1
- Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4
- LAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaTerminatedNCT00161239Not applicable
- Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant NephropathyCompletedNCT00160966Phase 4
- A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid ArthritisCompletedNCT00160602Phase 3
- Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular CarcinomaStatus unknownNCT00155272Phase 1/2
- Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 LevelsCompletedNCT00154193Phase 4
- Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)CompletedNCT00153530Phase 4
- A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)CompletedNCT00152490Phase 3
- Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).CompletedNCT00152425Phase 3
- A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid ArthritisCompletedNCT00152386Phase 3
- Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic DermatitisCompletedNCT00150059Phase 4
- Efficacy and Safety of Everolimus in de Novo Heart Transplant RecipientsCompletedNCT00150046Phase 3
- Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.Status unknownNCT00148551Phase 2/3
- Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationCompletedNCT00146614Phase 2
- Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNCT00146588Not applicable
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell TransplantationCompletedNCT00144703Phase 2
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2